Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2

NCT04611841 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-11-02

No results posted yet for this study

Summary

Сonducting in-depth medical and biological studies of the pathogenesis of the disease caused by the SARS-CoV-2 in Moscow, the Moscow region and some other regions of the Russian Federation.

Conditions

  • Covid19

Sponsors & Collaborators

  • Burnasyan Federal Medical Biophysical Center

    collaborator OTHER_GOV
  • Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

    collaborator OTHER_GOV
  • Moscow city hospital named after S.I. Spasokukotskiy

    collaborator UNKNOWN
  • Federal State Public Scientific Institution, Scientific Center for Family Health and Human Reproduction Problems

    collaborator OTHER
  • Federal State Budgetary Healthcare Institution, Hospital RAS

    collaborator UNKNOWN
  • Federal Research and Clinical Center of Physical-Chemical Medicine

    lead OTHER

Principal Investigators

  • Vadim Govorun, MD · FRCC PCM

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04611841 on ClinicalTrials.gov